https://www.cancer.gov/news-events/cancer-currents-blog/2021/fda-tecartus-adults-b-cell-all?cid=eb_govdel
Brexucabtagene autoleucel (Tecartus) has become the first CAR T-cell therapy approved to treat adults with B-cell precursor acute lymphoblastic leukemia (ALL)....
for someb celltecartusapprovedadults